Key indicators: single-crystal X-ray study; T = 446 K; mean (C-C) = 0.002 Å; disorder in main residue; R factor = 0.058; wR factor = 0.173; data-to-parameter ratio = 17.6. Bruker (2008). APEX2, SAINT and SADABS.
The title compound, C 22 H 21 FO 2 , exhibits substitutional disorder of the F atom and a H atom in the asymmetric unit with different occupancies, the refined F:H ratio being 0.80 (2):0.20 (2). The dihedral angle between the fluorinated benzene ring and the benzene ring of the chromanone system is 37.30 . There are two relatively high residual electrondensity peaks associated with the disorder.
Related literature
For the preparation, see: Shaikh et al. (2011) . For related structures, see: Gopaul et al. (2012) ; Marx et al. (2008); Suresh et al. (2007) . For the biological activity of this class of compound, see: du Toit et al. (2010) . This compound may undergo chemical conversion into the (E)-and (Z)-isomers, see: Kirkiacharian et al. (1984) . The title compound, 3-(4-cyclohexyl-3-fluorobenzylidene)chroman-4-one, belongs to the homoisoflavonoid class of compounds, which are α,β unsaturated carbonyl compounds containing two aromatic rings. They are a group of naturally occurring molecules that are structurally related to isoflavonoids but differ by containing one more carbon atoms (Kirkiacharian et al., 1984) . This compound may undergo chemical conversion into the (E)-and (Z)-isomers (Kirkiacharian et al., 1984) . The 3-benzylidene-4-chromanones have been shown to display a wide range of biological activities (du Toit et al., 2010) . The most commonly used procedure for the synthesis of homoisoflavonoids involves the condensation of chroman-4-one with an aromatic aldehyde in the presence of an acidic or basic catalyst (Shaikh et al., 2011) . We have recently been involved in the synthesis and characterization of fluorinated homoisoflavonoids in the search for lead pharmaceuticals (Gopaul et al., 2012) .
Experimental
In the molecular structure, the dihedral angle between the fluorinated benzene moiety and the benzene ring of the chromanone moiety is 37.30°. The cyclohexane moiety on the fluorinated benzene ring is attached to the least sterically hindered para-position of the phenyl ring and adopts a chair confirmation.
A mixture of chroman-4-one (1.00 g, 6.749 mmol), 3,4-difluorobenzaldehyde (1.15 g, 8.099 mmol) and 10-15 drops of piperidine in cyclohexane was heated at 80°C for 24 hrs. The reaction mixture was monitored for completion by thin layer chromatography. Upon completion, the reaction mixture was cooled, diluted with water and neutralized using 10%
HCl. The reaction mixture was extracted with ethyl acetate (3 × 30 ml). The ethyl acetate layers were combined, washed with brine (20 ml), water (2 × 10 ml) and dried over anhydrous magnesium sulfate. The solvent was reduced and the compound purified by column chromatography using silica gel (Merck 9385, 40-63 µm particle size) with a mobile phase of 2% ethyl acetate in hexane to yield the title compound. 
Figure 1
The asymmetric unit of the title compound with displacement ellipsoids drawn at the 50% probability level. The atoms F1a/F1b and H-8/H-13 are disordered and only F1a and H-8 are shown. Special details Experimental. Carbon-bound H-atoms were placed in calculated positions [C-H = 0.97 Å for Methylene H atoms, 0.98 Å for methine and 0.93 Å for aromatic H atoms; U iso (H) = 1.2U eq (C)] and were included in the refinement in the riding model approximation. Disorder: Disorder was found for the F-and H-atoms, which is not an uncommon situation. The disorder was modelled for F-and H-atoms (80:30) using PART instructions and the total occupancy at each atom site was kept as 1 during the refinement by means of a SUMFIX constraint. The F-atoms involved in disorder were modelled with anisotropic thermal parameters. Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. (10) 0.0255 (9) −0.0077 (7) −0.0028 (6) −0.0070 (7) C5 0.0147 (7) 0.0397 (10) 0.0221 (8) −0.0066 (6) 0.0001 (6) −0.0085 (7) C6 0.0111 (6) 0.0177 (7) 0.0106 (6) −0.0035 (5) −0.0004 (5) −0.0031 (5) C7 0.0165 (7) 0.0173 (7) 0.0144 (6) −0.0067 (5) −0.0008 (5) −0.0020 (5) C8 0.0161 (7) 0.0170 (7) 0.0197 (7) −0.0019 (5) 0.0003 (5) −0.0042 (6) F1B 0.023 (3) 0.034 (3) 0.032 (3) 0.009 (2) −0.007 (2) −0.014 (2) C10 0.0189 (7) 0.0172 (7) 0.0166 (7) −0.0026 (6) 0.0006 (5) −0.0053 (5) C11 0.0168 (7) 0.0154 (7) 0.0160 (7) −0.0054 (5) 0.0006 (5) −0.0029 (5) C12 0.0154 (7) 0.0151 (7) 0.0181 (7) −0.0034 (5) 0.0007 (5) −0.0034 (5) C13 0.0188 (7) 0.0143 (7) 0.0158 (7) −0.0049 (5) 0.0017 (5) −0.0047 (5) F1A 0.0210 (6) 0.0186 (6) 0.0182 (6) −0.0015 (4) −0.0006 (4) −0.0093 (4) C14 0.0151 (7) 0.0161 (7) 0.0194 (7) −0.0024 (5) −0.0004 (5) −0.0051 (5) C15 0.0133 (6) 0.0159 (7) 0.0184 (7) −0.0031 (5) −0.0001 (5) −0.0045 (5) C16 0.0137 (7) 0.0242 (8) 0.0158 (7) −0.0025 (6) 0.0006 (5) −0.0047 (6) C17 0.0168 (7) 0.0190 (7) 0.0189 (7) −0.0044 (5) −0.0020 (6) −0.0046 (6) C18 0.0197 (7) 0.0292 (9) 0.0197 (8 0.0155 (7) 0.0153 (7) 0.0190 (7) −0.0029 (5) −0.0020 (5) −0.0043 (5) C23 0.0142 (7) 0.0199 (7) 0.0205 (7) −0.0025 (5) −0.0007 (5) −0.0076 (6) O1 0.0133 (5) 0.0381 (7) 0.0171 (6) −0.0064 (5) 0.0002 (4) −0.0048 (5) O2 0.0140 (6) 0.0507 (9) 0.0273 (7) −0.0028 (5) 0.0010 (5 
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